These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2858521)

  • 1. Analysis of particulate contamination in ampoules using a light blockage particle analyser.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):13-6. PubMed ID: 2858521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate contamination in ampoules.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):53-5. PubMed ID: 2858528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
    Lee KR; Chae YJ; Cho SE; Chung SJ
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate contamination in plastic ampoules.
    Oppenheim RC; Gillies IR
    J Pharm Pharmacol; 1986 May; 38(5):344-7. PubMed ID: 2872309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety concerns with glass particle contamination: improving the standard guidelines for preparing medication injections.
    Chiannilkulchai N; Kejkornkaew S
    Int J Qual Health Care; 2021 Jun; 33(2):. PubMed ID: 34101800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particles in small volume injections.
    Taylor SA; Spence J
    J Pharm Pharmacol; 1983 Dec; 35(12):769-73. PubMed ID: 6141237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate and microbial contamination in in-use admixed parenteral nutrition solutions.
    Oie S; Kamiya A
    Biol Pharm Bull; 2005 Dec; 28(12):2268-70. PubMed ID: 16327163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particulate contamination of Australian ampoules.
    Gillies IR; Thiel WJ; Oppenheim RC
    J Pharm Pharmacol; 1986 Feb; 38(2):87-92. PubMed ID: 2870168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate contamination in solutions of antibiotics packed as dry powders in vials.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1988 May; 40(5):358-9. PubMed ID: 2899632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on insoluble microparticulate contamination at ampoule opening].
    Kawasaki Y
    Yakugaku Zasshi; 2009 Sep; 129(9):1041-7. PubMed ID: 19721379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate contamination of sterile syringes and needles.
    Taylor SA
    J Pharm Pharmacol; 1982 Aug; 34(8):493-5. PubMed ID: 6126558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of official instrumental methods for the determination of particulate matter contamination in large volume parenteral solutions.
    Montanari L; Pavanetto F; Conti B; Ponci R; Grassi M
    J Pharm Pharmacol; 1986 Nov; 38(11):785-90. PubMed ID: 2879006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glass particulate adulterated in single dose ampoules: A patient safety concern.
    Unahalekhaka A; Nuthong P
    J Clin Nurs; 2023 Apr; 32(7-8):1135-1139. PubMed ID: 35484835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate contaminants of intravenous medications and infusions.
    Backhouse CM; Ball PR; Booth S; Kelshaw MA; Potter SR; McCollum CN
    J Pharm Pharmacol; 1987 Apr; 39(4):241-5. PubMed ID: 2884285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glass particle contamination threat in nursing practice: A pilot study.
    Erkoc Hut A; Yazici ZA
    J Adv Nurs; 2021 Jul; 77(7):3189-3191. PubMed ID: 33855755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of particulate contamination in intravenous administration sets.
    Di Paolo ER; Hirschi B; Pannatier A
    Pharm Weekbl Sci; 1990 Oct; 12(5):190-5. PubMed ID: 2255588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.